| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.21B | 6.17B | 5.47B | 5.76B | 5.22B | 5.12B |
| Gross Profit | 2.49B | 2.62B | 2.22B | 1.66B | 1.37B | 1.66B |
| EBITDA | 7.73B | 13.37B | 4.94B | 5.30B | 9.90B | 730.00M |
| Net Income | 12.47B | 12.37B | 6.61B | 10.11B | 18.73B | 7.45B |
Balance Sheet | ||||||
| Total Assets | 72.59B | 72.59B | 61.82B | 65.08B | 71.34B | 55.73B |
| Cash, Cash Equivalents and Short-Term Investments | 18.90B | 18.90B | 18.99B | 20.87B | 13.57B | 6.03B |
| Total Debt | 16.45B | 16.45B | 16.24B | 16.91B | 17.16B | 9.12B |
| Total Liabilities | 21.46B | 21.46B | 20.53B | 20.45B | 20.82B | 12.54B |
| Stockholders Equity | 51.05B | 51.05B | 41.26B | 44.59B | 50.42B | 43.07B |
Cash Flow | ||||||
| Free Cash Flow | 1.86B | 1.81B | 978.00M | -349.00M | -817.00M | 54.00M |
| Operating Cash Flow | 1.95B | 1.92B | 1.04B | -120.00M | -605.00M | 159.00M |
| Investing Cash Flow | 12.02B | 11.88B | 209.00M | 12.64B | 4.39B | -3.22B |
| Financing Cash Flow | -8.84B | -8.74B | -8.12B | -12.45B | 2.40B | 2.45B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $142.63B | 12.68 | 27.01% | 0.23% | 12.49% | 99.03% | |
73 Outperform | $16.86B | 8.65 | 51.49% | ― | 16.79% | 819.94% | |
72 Outperform | $34.77B | 101.06 | 15.22% | ― | 69.71% | ― | |
71 Outperform | $25.04B | 18.59 | 14.47% | 0.99% | 13.86% | 80.97% | |
67 Neutral | $81.73B | 96.21 | 10.11% | ― | 24.46% | ― | |
64 Neutral | $37.90B | 34.57 | 3.08% | ― | -2.70% | -59.65% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% |